Is febuxostat associated with higher risk of cardiovascular death than allopurinol in treating gout or asymptomatic hyperuricemia?
@article{APM98611, author = {Jian-Hao Deng and Guo-Wei Zhong and Jia-Xing Zhang}, title = {Is febuxostat associated with higher risk of cardiovascular death than allopurinol in treating gout or asymptomatic hyperuricemia?}, journal = {Annals of Palliative Medicine}, volume = {11}, number = {8}, year = {2022}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/98611} }